Good Medicine: Pharmaceutical-Biotech Sector New Site Build Construction Investment Nears $20 Billion

SUGAR LAND--January 29, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--As the global economic headache spirals into a migraine, the pharmaceutical-biotech industry capital injection is just what the doctor ordered. There is no shortage of grassroot construction within the industry, as a recent analysis of reported projects (Industrial Info Resources Pharmaceutical Biotech database) revealed 191 sites scattered across the globe translating into a potential total investment value (TIV) of $19.7 billion. Within this article: Details of pharmaceutical-biotech industry grassroot investments, such as those by Novo Nordisk AS (NYSE:NVO)